Infinium EPIC v2 Methylation Kits
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), specifically the Center for Research on Genomics and Global Health, has issued a Presolicitation for Infinium EPIC v2 Methylation Kits. This requirement is for a research study exploring differential methylation among a cohort of individuals. Responses are due June 12, 2026.
Scope of Work
The contractor shall provide four (4) Infinium Methylation EPIC v2 kits (96-sample kits). These kits are manufactured by Illumina and are designed for studying methylation changes across the genome. The government will be responsible for storing the genotyping kits in environmental conditions recommended by the manufacturer and using them in accordance with manufacturer instructions. The NHGRI Genomics Core will generate the methylation genotypes using its specialized equipment (Illumina iScan, Illumina Autoloader, and Tecan Liquid Handling Robot).
Background and Purpose
The Center for Research on Genomics and Global Health is conducting a study to explore differential methylation among a cohort of individuals using Illumina's Infinium Methylation EPIC v2 beadchip kits. This order is specifically for these methylation arrays to be implemented as part of this study. The product is for one-time use, with genotyping expected to be completed within one year.
Contract & Timeline
- Type: Presolicitation
- Set-Aside: None specified
- Product Service Code: 6505 (Drugs And Biologicals)
- Response Due: June 12, 2026, 1:00 PM EDT
- Published: June 2, 2026
- Place of Performance: Bethesda, MD 20892, United States
Contact Information
For inquiries, please contact John Burton at burtonjo@mail.nih.gov.